Cognition Therapeutics (CGTX) Institutional Ownership → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free CGTX Stock Alerts $1.98 +0.02 (+1.02%) (As of 12:25 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Cognition Therapeutics (NASDAQ:CGTX)CurrentInstitutional OwnershipPercentage43.35%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$2.40MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$226.23K Get CGTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Cognition Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CGTX Institutional Buying and Selling by Quarter Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. Cognition Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024 Levin Capital Strategies L.P.30,000$55K0.0%N/A0.075% 5/16/2024 AWM Investment Company Inc.650,000$1.18M0.2%N/A1.623% 5/14/2024 Carlson Capital L P213,995$389K0.0%-10.1%0.534% 5/14/2024 CM Management LLC175,000$318K0.3%N/A0.437% 5/10/2024 Tocqueville Asset Management L.P.26,000$47K0.0%N/A0.065% 5/8/2024 Hohimer Wealth Management LLC225,000$410K0.1%N/A0.562% Get the Latest News and Ratings for CGTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/5/2024 Twin Focus Capital Partners LLC93,372$173K0.0%N/A0.291% 2/8/2024 Texas Capital Bank Wealth Management Services Inc55,395$102K0.0%N/A0.172% 2/1/2024 Sigma Planning Corp28,550$53K0.0%N/A0.089% 10/23/2023Steward Financial Group LLC40,874$58K0.0%N/A0.135% 7/28/2023 Voss Capital LLC60,222$110K0.0%-62.4%0.206% 5/12/2023 Voss Capital LLC159,973$317K0.0%-4.2%0.546% 5/12/2023 FCA Corp TX51,471$102K0.0%N/A0.176% 2/16/2023 AIGH Capital Management LLC2,037,853$4.28M1.4%+155.3%7.030% 2/13/2023 Northeast Financial Consultants Inc24,500$51K0.0%N/A0.085% 2/13/2023 Voss Capital LLC166,903$350K0.1%-23.8%0.576% 2/13/2023Financial Partners Capital Management LLC14,228$30K0.0%N/A0.049% 2/7/2023Commonwealth Equity Services LLC189,307$397K0.0%-13.6%0.653% 2/6/2023 Neumann Capital Management LLC33,382$70K0.0%N/A0.115% 1/31/2023 Kestra Advisory Services LLC50,618$106K0.0%+237.5%0.175% 1/20/2023 Diligent Investors LLC20,000$42K0.0%-34.5%0.069% 12/13/2022 Perigon Wealth Management LLC36,900$70K0.0%-70.0%0.127% 11/15/2022 Carlson Capital L P100,000$190K0.0%N/A0.440% 11/14/2022 Worth Venture Partners LLC200,188$380K0.2%-12.3%0.881% 11/10/2022 Rock Creek Group LP50,000$95K0.0%-37.3%0.220% 11/2/2022 Voss Capital LLC219,100$416K0.1%-29.2%0.965% 11/1/2022 P.A.W. Capital Corp100,000$190K0.3%-25.9%0.440% 10/12/2022 Wealth Alliance Advisory Group LLC18,500$35K0.0%N/A0.081% 8/13/2022 Voss Capital LLC309,472$653K0.2%+1,070.5%1.363% 8/13/2022 Prosight Management LP120,198$254K0.2%-49.9%0.532% 8/11/2022 Perigon Wealth Management LLC122,846$259K0.0%N/A0.544% 8/8/2022 Rock Creek Group LP79,751$170K0.0%+201.6%0.353% 8/1/2022 Castle Wealth Management LLC43,380$92K0.1%N/A0.192% 7/19/2022Commonwealth Equity Services LLC214,961$453K0.0%+1,447.6%0.951% 7/13/2022 P.A.W. Capital Corp135,000$285K0.4%+12.5%0.597% 5/17/2022 Prosight Management LP240,080$660K0.4%-20.5%1.062% 5/4/2022Commonwealth Equity Services LLC13,890$38K0.0%N/A0.061% 4/26/2022 Diligent Investors LLC30,520$84K0.0%N/A0.135% 4/26/2022 Kestra Advisory Services LLC238,666$656K0.0%+150.9%1.057% 4/21/2022 P.A.W. Capital Corp120,000$330K0.3%+20.0%0.531% Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide4/14/2022 Bangor Savings Bank18,496$51K0.0%N/A0.082% 2/10/2022 B. Riley Financial Inc.30,904$195K0.0%N/A0.140% 2/10/2022 American Financial Group Inc.205,000$1.30M0.4%N/A0.930% 2/10/2022 AIGH Capital Management LLC25,496$161K0.0%N/A0.116% 2/10/2022 P.A.W. Capital Corp100,000$632K0.6%N/A0.454% (Data available from 1/1/2016 forward) CGTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CGTX shares? During the previous two years, 26 institutional investors and hedge funds held shares of Cognition Therapeutics. The most heavily invested institutionals were AIGH Capital Management LLC ($4.28M), AWM Investment Company Inc. ($1.18M), Hohimer Wealth Management LLC ($410K), Commonwealth Equity Services LLC ($397K), Carlson Capital L P ($389K), Worth Venture Partners LLC ($380K), and CM Management LLC ($318K).Learn more on CGTX's institutional investors. What percentage of Cognition Therapeutics stock is owned by institutional investors? 43.35% of Cognition Therapeutics stock is owned by institutional investors. Learn more on CGTX's institutional investor holdings. Which institutional investors have been buying Cognition Therapeutics stock? Of the 23 institutional investors that purchased Cognition Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AIGH Capital Management LLC ($1.24M), AWM Investment Company Inc. ($650K), Voss Capital LLC ($283.03K), Hohimer Wealth Management LLC ($225K), Commonwealth Equity Services LLC ($201.07K), CM Management LLC ($175K), and Perigon Wealth Management LLC ($122.85K). How much institutional buying is happening at Cognition Therapeutics? Institutional investors have bought a total of 3,560,050 shares in the last 24 months. This purchase volume represents approximately $7.07M in transactions. Which Cognition Therapeutics major shareholders have been selling company stock? Of the 9 institutional investors that sold Cognition Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Voss Capital LLC ($249.25K), Prosight Management LP ($119.88K), Perigon Wealth Management LLC ($85.95K), P.A.W. Capital Corp ($35K), Commonwealth Equity Services LLC ($29.76K), Rock Creek Group LP ($29.75K), and Worth Venture Partners LLC ($27.98K). How much institutional selling is happening at Cognition Therapeutics? Institutional investors have sold a total of 612,098 shares in the last 24 months. This volume of shares sold represents approximately $1.20M in transactions. Related Companies: Precision BioSciences Institutional Ownership Elutia Institutional Ownership Instil Bio Institutional Ownership Gritstone bio Institutional Ownership CEL-SCI Institutional Ownership SCYNEXIS Institutional Ownership Athira Pharma Institutional Ownership Protalix BioTherapeutics Institutional Ownership Atara Biotherapeutics Institutional Ownership AlloVir Institutional Ownership This page (NASDAQ:CGTX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cognition Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.